Antioxidant, antibacterial, and antileishmanial potential of Micromeria nervosa extracts and molecular mechanism of action of the bioactive compound.


Journal

Journal of applied microbiology
ISSN: 1365-2672
Titre abrégé: J Appl Microbiol
Pays: England
ID NLM: 9706280

Informations de publication

Date de publication:
16 Feb 2023
Historique:
received: 09 04 2022
revised: 15 10 2022
accepted: 16 01 2023
pubmed: 18 1 2023
medline: 18 2 2023
entrez: 17 1 2023
Statut: ppublish

Résumé

This study aimed to determine the antibacterial and antileishmanial potential of Micromeria nervosa extracts. The identification of the antileishmanial compound and the study of its molecular mechanism of action have also been undertaken. Ethanol extract showed high polyphenol content and diethyl ether extract exhibited high DPPH scavenging and low beta-carotene bleaching activity (IC50 = 13.04 ± 0.99 and 200.18 ± 3.32 μg mL-1, respectively). However, diethyl ether extract displayed high antibacterial activity against Gram-positive strains including methicillin-resistant Staphylococcus aureus (MIC = 31.25 μg mL-1), Staph. aureus ATCC6538 (MIC = 62.5 μg mL-1), and Listeria monocytogenes ATCC 19115 (MIC = 125 μg mL-1), as well as high antileishmanial activity against the promastigote forms of L. infantum and L. major (IC50 = 11.45 and 14.53 μg mL-1, respectively). The active compound was purified using bioassay-guided fractionation and thin layer chromatography, and identified as ursolic acid using high-performance liquid chromatography coupled with a photodiode array and mass spectrometry. The purified compound was strongly inhibitory against the promastigote and amastigote forms of L. infantum and L. major (IC50 = 5.87 and 6.95 μg mL-1 versus 9.56 and 10. 68 μg mL-1, respectively) without overt cytotoxicity against Raw 264.7 macrophage cells (SI = 13.53 and 11.43, respectively). The commercial compound (ursolic acid) showed similar activity against amastigotes and promastigotes forms of L. infantum and L. major. Moreover, its molecular mode of action against leishmaniasis seems to involve the expression of the ODC and SPS genes involved in thiol pathway. Extracts of M. nervosa can be considered as a potential alternative to antimicrobial and antileishmanial drugs.

Identifiants

pubmed: 36649680
pii: 6989852
doi: 10.1093/jambio/lxad007
pii:
doi:

Substances chimiques

Antioxidants 0
Ether 0F5N573A2Y
Plant Extracts 0
Antiprotozoal Agents 0
Anti-Bacterial Agents 0
Anti-Infective Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Applied Microbiology International.

Auteurs

Sarra Kefi (S)

Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050 Hammam-lif, Tunisia.
University of Tunis-El Manar, Campus Universitaire Farhat Hached, BP-94 Rommana, 1068 Tunis, Tunisia.

Rym Essid (R)

Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050 Hammam-lif, Tunisia.
University of Tunis-El Manar, Campus Universitaire Farhat Hached, BP-94 Rommana, 1068 Tunis, Tunisia.

Adele Papetti (A)

Laboratory of Nutraceutical and Food Chemical-Toxicological Analysis, Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.

Ghassen Abid (G)

Laboratory of Legumes, Center of Biotechnology of Borj Cedria, BP-901, 2050 Hammam-lif, Tunisia.

Lamjed Bouslama (L)

Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050 Hammam-lif, Tunisia.

Ezzedine Aouani (E)

Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050 Hammam-lif, Tunisia.
Faculty of Sciences of Bizerte (FSB)-University of Carthage, 7021 Bizerte, Tunisia.

Olfa Tabbene (O)

Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050 Hammam-lif, Tunisia.

Ferid Limam (F)

Laboratory of Bioactive Substances, Center of Biotechnology of Borj Cedria, BP-901, 2050 Hammam-lif, Tunisia.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Fragaria Light Plant Leaves Osmosis Stress, Physiological

Classifications MeSH